Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis

Neuroscience

Volumn 105, Issue 4, 2001, Pages 1055-1065

  Espejo, C ^a   Carrasco, J ^a   Hidalgo, J ^a   Penkowa, M ^b   Garcia, A ^a   Saez Torres I ^a   Martinez Caceres E M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antioxidant proteins; Interferon ; Multiple sclerosis; Neuroprotein; Oxidative stress

Indexed keywords

ANTIOXIDANT; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; ISOPROTEIN; METALLOTHIONEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BRAIN INJURY; CELL INFILTRATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GRAY MATTER; IMMOBILIZATION STRESS; KNOCKOUT MOUSE; MACROPHAGE; MALE; MONOCYTE; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; WHITE MATTER;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MACROPHAGES; MALE; METALLOTHIONEIN; MICE; MICE, KNOCKOUT; MICROGLIA; PROTEIN ISOFORMS; RECEPTORS, INTERFERON;

EID: 0035934271     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00252-4     Document Type: Article

References (63)

1. Expression of growth inhibitory factor (metallothionein-III) mRNA and protein following excitotoxic immature brain injury
2. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: Astroglial response and metallothionein expression
3. Gene targeting in normal somatic cells: Inactivation of the interferon-γ receptor in myoblast
4. Nitric oxide mediated metallothionein induction by lipopolysaccharide
5. Astrocyte metallothioneins (MTs) and their neuroprotective role
6. Metallothioneins in brain - The role in the physiology and pathology
7. Effect of stress on mouse and rat brain metallothionein I and III mRNA levels
8. Metallothionein (MT)-III: Generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains
9. Localization of metallothionein-I and -III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin-6
10. Inducible nitric oxide synthase gene expression and enzime activity correlate with disease activity in murine EAE
11. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates EAE in SJL mice
12. Temporalspatial patterns of expression of metallothionein-I and -III and other stress related genes in rat brain after kainic acid-induced seizures
13. Endotoxin induction of murine metallothionein gene expression
14. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
15. Antisense knockdown of inducible nitric oxide sinthase inhibits induction of EAE in SJL mice
16. Changes in brain gene expression shared by scrapie and Alzheimer disease
17. Expression and regulation of brain metallothionein
18. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF)
19. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene
20. Endotoxin and intracerebroventricular injection of IL-1 and IL-6 induce rat brain metallothionein-I and III
21. Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice
22. Liver, brain, and heart metallothionein induction by stress
23. Liver and brain metallothionein regulation in transgenic mice overexpressing IL-6 and in mice carrying a null mutation in the IL-6 gene
24. Regulation of brain metallothioneins
25. Local nitric oxide production in viral and autoimmune diseases of the central nervous system
26. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis
27. Immune response in mice that lack the interferon-γ receptor
28. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice
29. Activated human T cell, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?
30. Immunopathology of multiple sclerosis: Report on an International Meeting Held at the Institute of Neurology of the University of Vienna
31. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes
32. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: An electron paramagnetic resonance study
33. Immunological aspects of demyelinating diseases
34. b mice: Fine specifity and T cell Vβ expression of encephalitogenic T cell
35. Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expression
36. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with EAE
37. Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient
38. MT-III, a brain-specific member of metallothionein family
39. Impaired inflammatory response to glia cell death in genetically metallothionein-I and -II-deficient mice
40. Increased astrocytic expression of metallothioneins I+II in brainstem of adult rats treated with 6-aminonicotinamide
41. Disruption of the blood-brain interface in neonatal rat neocortex induces a transient expression of metallothionein in reactive astrocytes
42. Ectopic expression of metallothionein-III causes pancreatic acinar cell necrosis in transgenic mice
43. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia
44. Demyelinating diseases
45. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats
46. Aggravation of EAE by administration of nitric oxide synthase inhibitors
47. Mice with an inactivation of the inducible nitric oxide sinthase gene are susceptible to experimental autoimmune encephalomyelitis
48. Oxygen free radicals and metallothionein
49. Metallothionein protects against cytotoxic and DNA-damaging effects of NO
50. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties
51. The effects of 6-hydroxydopamine and oxidative stress on the level of brain metallothionein
52. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis
53. Oxidative stress in patients with multiple sclerosis
54. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals
55. Metallothionein expression prevents apoptosis: A study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line
56. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein
57. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia
58. Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse
59. Oxidative damage to DNA in plaques of MS brains
60. Coordinate regulation of mouse metallothionein I and II genes by heavy metals and glucocorticoids
61. Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury
62. Chemical modulation of metallothionein I and III mRNA in mouse brain